Clinical utility of pharmacogenomics in the management of hepatitis C

Clinical utility of pharmacogenomics in the management of hepatitis C

Julieta Trinks,1,2 María Laura Hulaniuk,1 María Ana Redal,1,3 Diego Flichman2,4 1Instituto de Ciencias Básicas y Medicina Experimental, Hospital Italiano de Buenos Aires, 2National Scientific and Technical Research Council, 3Instituto Universitario del Hospital Ital...

Full description

Bibliographic Details
Main Authors:	Trinks J, Hulaniuk ML, Redal MA, Flichman D
Format:	Article
Language:	English
Published:	Dove Medical Press 2014-10-01
Series:	Pharmacogenomics and Personalized Medicine
Online Access:	http://www.dovepress.com/clinical-utility-of-pharmacogenomics-in-the-management-of-hepatitis-c-peer-reviewed-article-PGPM

Similar Items

Hepatitis C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals
by: Trinks J, et al.
Published: (2017-03-01)

State of Art of Cancer Pharmacogenomics in Latin American Populations
by: Andrés López-Cortés, et al.
Published: (2017-05-01)

A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.
by: Clint Mizzi, et al.
Published: (2016-01-01)

Clinical use of pharmacogenomics
by: Telenti Amalio
Published: (2012-05-01)

Clinical implementation of RNA signatures for pharmacogenomic decision-making
by: Tang W, et al.
Published: (2011-09-01)

Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.
by: Clint Mizzi, et al.
Published: (2017-01-01)

Pharmacogenomics of CYP2C9: Functional and Clinical Considerations
by: Ann K. Daly, et al.
Published: (2017-12-01)

INTEGRATING PHARMACOGENOMICS INTO CLINICAL PRACTICE
by: Gurinder Johal, et al.
Published: (2016-05-01)

Translating pharmacogenomics: challenges on the road to the clinic.
by: Jesse J Swen, et al.
Published: (2007-08-01)

Pharmacogenomics of drug efficacy in the interferon treatment of chronic hepatitis C using classification algorithms
by: Wan-Sheng Ke, et al.
Published: (2010-06-01)

Update on the pharmacogenomics of pain management
by: Kaye AD, et al.
Published: (2019-07-01)

Clinical pharmacogenomics and concept of personalized medicine
by: Babić Nikolina
Published: (2012-01-01)

Clinical Application and Educational Training for Pharmacogenomics
by: Jason W. Guy, et al.
Published: (2020-09-01)

Current clinical evidence on pioglitazone pharmacogenomics
by: Marina eKawaguchi-Suzuki, et al.
Published: (2013-11-01)

Pharmacogenomics and Opioid Analgesics: Clinical Implications
by: Eugenia Yiannakopoulou
Published: (2015-01-01)

Pharmacogenomics Statins: Biomarkers for Clinical Prediction
by: Herni Suprapti
Published: (2018-09-01)

Pharmacogenomics: introduction and use in clinical practice
by: Saunders Hollie, et al.
Published: (2020-06-01)

Clinical and Pharmacogenomic Evaluation of Tacrolimus Formulations
by: Tremblay, Simon
Published: (2018)

Addressing Barriers to Clinical Implementation of Pharmacogenomics
by: Wiley, Laura Katherine
Published: (2016)

Pharmacogenomic Biomarkers
by: Sandra C. Kirkwood, et al.
Published: (2002-01-01)

Leveraging the utility of pharmacogenomics in psychiatry through clinical decision support: a focus group study
by: Andrew Goodspeed, et al.
Published: (2019-08-01)

PharmaKU: A Web-Based Tool Aimed at Improving Outreach and Clinical Utility of Pharmacogenomics
by: Sumi Elsa John, et al.
Published: (2021-03-01)

The fallacy of racial pharmacogenomics
by: S.D.J. Pena
Published: (2011-04-01)

The fallacy of racial pharmacogenomics
by: S.D.J. Pena
Published: (2011-04-01)

Pharmacogenomics From Basic Research to Clinical Implementation
Published: (2022)

Automated Pharmacogenomic Reports for Clinical Genome Sequencing
by: Amr, S.S, et al.
Published: (2022)

Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Letter]
by: Roman YM
Published: (2021-03-01)

Utilizing a user-centered approach to develop and assess pharmacogenomic clinical decision support for thiopurine methyltransferase
by: Khoa A. Nguyen, et al.
Published: (2019-10-01)

Prevalence and Factors Related to Natural Resistance-Associated Substitutions to Direct-Acting Antivirals in Patients with Genotype 1 Hepatitis C Virus Infection
by: Isabella Esposito, et al.
Published: (2018-12-01)

Exome-Wide Analysis of the DiscovEHR Cohort Reveals Novel Candidate Pharmacogenomic Variants for Clinical Pharmacogenomics
by: Maria-Theodora Pandi, et al.
Published: (2020-05-01)

Landmarks of pharmacogenomics and some considerations for clinical practice
by: David Nana Ampong
Published: (2019-12-01)

Clinical Application and Evaluation of Pharmacogenomics in Tumor Chemotherapy
by: Jifeng Feng
Published: (2014-03-01)

Pharmacogenomic Testing: Clinical Evidence and Implementation Challenges
by: Catriona Hippman, et al.
Published: (2019-08-01)

Pharmacogenomics: From Basic Research to Clinical Implementation
by: Laura B. Scheinfeldt
Published: (2021-08-01)

The Association of Warfarin Dosage in Clinical Use and Pharmacogenomics
by: Meng-Lin Wu, et al.
Published: (2007)

Pharmacogenomics of Antibiotics
by: Gabriele Stocco, et al.
Published: (2020-08-01)

Pharmacogenomics in the newborn
by: Mirta Corsello, et al.
Published: (2013-08-01)

Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter]
by: Takahashi PY, et al.
Published: (2021-05-01)

Pharmacogenomics of Cardiovascular Pharmacology: Pharmacogenomic Network of Cardiovascular Disease Models
by: Toshio Tanaka, et al.
Published: (2008-01-01)

Chapter 7: Pharmacogenomics.
by: Konrad J Karczewski, et al.
Published: (2012-01-01)

Cannot write session to /tmp/vufind_sessions/sess_iru9o6j0gi13jifckvlum4cqd0